Skyepharma rockets on regulatory approval

SkyePharma said the European Commission had given it the go-ahead to start marketing its asthma medicine, flutiform, across the continent.

SkyePharma said the European Commission had given it the go-ahead to start marketing its asthma medicine, flutiform, across the continent.

The firm said the European Commission's decision was binding and 21 member states were now required to grant national marketing authorisations or approvals consistent with the decision.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
MoneyWeek

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.